UTAH MEDICAL PRODUCTS, INC. Other Long-term Debt, Noncurrent
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Other Long-term Debt, Noncurrent of $241.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:OtherLongTermDebtNoncurrent · last filed 2025-11-14
- 2025-09-30: Other Long-term Debt, Noncurrent $241.00K.
- 2025-06-30: Other Long-term Debt, Noncurrent $0.00.
- 2025-03-31: Other Long-term Debt, Noncurrent $0.00.
- 2024-12-31: Other Long-term Debt, Noncurrent $282.00K; Other Long-term Debt, Noncurrent as first filed $0.00.
| Period end | Other Long-term Debt, Noncurrent | Other Long-term Debt, Noncurrent as first filed |
|---|---|---|
| 2025-09-30 | $241.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $282.00K 10-Q · filed 2025-11-14 | $0.00 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |